Dude.
You are doubling down on being wrong.$40 million cap raise is different to the $40 million loan facility.
Section does not include proceeds from the cap raise. Why are you blatantly ignoring that fact?
If you're going to arbitrarily conflate everything at least be consistent and add up everything:$40mCR + $40 facility + $48 cash =$128 million
You're arguing $48m = 3Q, so $88m is 6Q. Possibly 9Q with the additional $40.
You've ignored 7.6 detailing principal repayments for oaktree will be after a 3-year interest only period. You've ignored Novaquest repayments being after the first commercial sales of Remestemcel.
Again - why have you missed such key details @whytee?
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-47
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |